Miglitol - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for miglitol and what is the scope of patent protection?

Miglitol is the generic ingredient in two branded drugs marketed by Pfizer and Westminster Pharms, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for miglitol. Two suppliers are listed for this compound.

Summary for miglitol

US Patents:	0
Tradenames:	2
Applicants:	2
NDAs:	2
Drug Master File Entries:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	88
Clinical Trials:	13
Patent Applications:	7,073
Drug Prices:	Drug price trends for miglitol
What excipients (inactive ingredients) are in miglitol?	miglitol excipients list
DailyMed Link:	miglitol at DailyMed

See drug prices for miglitol

Recent Clinical Trials for miglitol

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Zambia	Phase 3
University Teaching Hospital, Lusaka, Zambia	Phase 3
Drug Safety and Effectiveness Network, Canada

See all miglitol clinical trials

Pharmacology for miglitol

Drug Class	alpha-Glucosidase Inhibitor
Mechanism of Action	alpha Glucosidase Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for miglitol

A10BF	Alpha glucosidase inhibitors
A10B	BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10	DRUGS USED IN DIABETES
A	Alimentary tract and metabolism

US Patents and Regulatory Information for miglitol

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Westminster Pharms	MIGLITOL	miglitol	TABLET;ORAL	203965-001	Feb 24, 2015	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Westminster Pharms	MIGLITOL	miglitol	TABLET;ORAL	203965-003	Feb 24, 2015	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-002	Dec 18, 1996	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-003	Dec 18, 1996	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for miglitol

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-001	Dec 18, 1996	⤷ Sign Up	⤷ Sign Up
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-003	Dec 18, 1996	⤷ Sign Up	⤷ Sign Up
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-002	Dec 18, 1996	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.